Dis,
Thank you for your criticism.
Quote:
"A restricted Relenza supply benefits the sale of GSK Pandamic Flu Vaccines. This is reflected in the disproportionate sale of Relenza to GSK Vaccines and Roche's performance."
This a Rubbish with a capital R. You use a (flu) vaccine to prevent flu and you use an antiviral to treat a person with flu IF THEY REQUIRE TREATMENT - the vast majority do not. Are you seriously suggesting that GSK will with hold Relenza supply so that there will be 1000's of extra deaths; and they will use this post mortem analysis to promote their vaccine for future years. Get real!
You obviously new to BTA forum and have not read earlier postings. I hope I am able to assist you by repeating the earlier post:
Buyer: Mr Witty, my government want to place 10 million courses of Relenza.
Mr Witty: No problem. Let me look at my production schedule. Yes, we will deliver the first 3 million in July 2010 and the remainder in September.
Buyer: Hello, are you for real? By then my people will be dead and the pandemic may be over!
Mr Witty: No they wont be dead. You can buy 30 million doses of our Pandemic Vaccines for the same amount of money that you could only buy 10 million of Relenza.
Buyer: You are a genius. They don’t call you Witty for no reason!
Dis, obviously the above is a fictional conversation that could be taking place right now. I hope it is simple enough for you.
- Forums
- ASX - By Stock
- more production increases coming??
Dis, Thank you for your criticism. Quote:"A restricted Relenza...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online